APA

Shah S., Carriveau W. J., Li J., Campbell S. L., Kopinski P. K., Lim H., Daurio N., Trefely S., Won K., Wallace D. C., Koumenis C., Mancuso A. & Wellen K. E. (20180117). Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. : Oncotarget.

Chicago

Shah Supriya, Carriveau Whitney J, Li Jinyang, Campbell Sydney L, Kopinski Piotr K, Lim Hee-Woong, Daurio Natalie, Trefely Sophie, Won Kyoung-Jae, Wallace Douglas C, Koumenis Constantinos, Mancuso Anthony and Wellen Kathryn E. 20180117. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. : Oncotarget.

Harvard

Shah S., Carriveau W. J., Li J., Campbell S. L., Kopinski P. K., Lim H., Daurio N., Trefely S., Won K., Wallace D. C., Koumenis C., Mancuso A. and Wellen K. E. (20180117). Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. : Oncotarget.

MLA

Shah Supriya, Carriveau Whitney J, Li Jinyang, Campbell Sydney L, Kopinski Piotr K, Lim Hee-Woong, Daurio Natalie, Trefely Sophie, Won Kyoung-Jae, Wallace Douglas C, Koumenis Constantinos, Mancuso Anthony and Wellen Kathryn E. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. : Oncotarget. 20180117.